NASDAQ: IPHAInnate Pharma Sa Stock Ownership - Who owns Innate Pharma Sa?
Insider buying vs selling
Have Innate Pharma Sa insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when IPHA insiders and whales buy or sell their stock.
IPHA Shareholders
What type of owners hold Innate Pharma Sa stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Morgan Stanley | 0.06% | 51,224 | $106.55k | Institution |
| Citadel Advisors LLC | 0.03% | 26,617 | $55.36k | Institution |
| Millennium Management LLC | 0.01% | 11,661 | $24.25k | Institution |
| Ubs Group Ag | 0.01% | 5,957 | $12.39k | Institution |
| Gamma Investing LLC | 0.00% | 3,456 | $7.19k | Institution |
| Rhumbline Advisers | 0.00% | 470 | $977.60 | Institution |
| Barclays PLC | 0.00% | 307 | $638.56 | Institution |
| Optiver Holding Bv | 0.00% | 101 | $210.08 | Institution |
| Principal Securities Inc | 0.00% | 45 | $93.60 | Institution |
| Concourse Financial Group Securities Inc | 0.00% | 0 | $0.00 | Institution |
IPHA vs Biotech Stocks
Innate Pharma Sa Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.